The impact of rescue or maintenance therapy with EGFR TKIs for Stage IIIb-IV non-squamous non-small-cell lung cancer patients requiring mechanical ventilation

Table 3 EGFR mutation, non-smoking percentage, and SAPS II and SOFA scores of patients taking EGFR TKIs for rescue/maintenance therapy (n = 23)

Variables	Ventilator-dependent >100 days or non-survivors	Weaned from the ventilator
Subjects	18	5
EGFR mutation status of 8 samples	6 positive	1 positive
EGFR mutation status of 8 samples	1 negative	1 positive
*Smoking	4	1
Nonsmoking	7	3
Positive EGFR mutation + nonsmoking	13 (72)	4 (80)
SAPS II score	54.0 (23.0)	46.0 (20.5)
SOFA score	8.0 (4.5)	5.0 (3.5)

*Excluding patients receiving EGFR mutation test.
Data are median (inter-quartile range) for quantitative data and number (%) for qualitative data.
See Tables 1 for abbreviations.

ISSN: 1471-2253